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smooth muscle cells. The aim of the present study is to investigate roles of AM in 
patients with coronary altery disease (CAD). [Methods]: Plasma AM concentrations from 
the femoral vein and coronary sinus were measured before and after coronary interven- 
tion in 41 patients with CAD (35 males, 6 females, 66+6y/o. mean+SD: POBA 17, stents 
24). Patients included 20% of family histoty of CAD, OMI 30%, DM 35%, smoker 50%, 
hyperlipidemia 63%, and HT 66%. Relations among plasma AM and various coronary 
risk factors were analyzed.[Results]: Baseline AM was higher in patients with the greater 
diameter of stenotic vessels. Neither insertion of introducer sheaths nor diagnostic cathe- 
terization influenced the plasma AM. Coronary interventions increased plasma AM signif- 
icantly in both POBA and stent group (10.7+3.2 vs. 12.6+4.5 fmollml, n=41,p<0.0001). 
Coronary sinus blood sampling showed greater increase of plasma AM compared to the 
systemic vein (+28% vs. +14%). The presence of hyperlipidemia. larger target vessel 
size and smaller number of diseased vessels were also significantly correlated with the 
more increase in plasma AM by the intewention. In the restenosis group, baseline 
plasma AM was significantly lower compared to the non-restenosis group (6.6+1.4 vs. 
11+3.4 fmollml, ~~0.05). Among other factors, CRP was higher in the restenosis group 
(0.32+0.15 vs. 0.16+0.10, p<O.Ol). In the hyper lipidemia group, patients with the higher 
AM (~15 fmollml) showed the lower restenosis rate (17%) compared to the patients with 
the lower AM (>15 fmollml) group (50%). [Conclusions]: Plasma adrenomedullin was 
increased by coronary interventions. Plasma AM was higher in non-restenosis group. 
These results suggest that AM could be one of predictors for restenosis, and AM may 
play a role to suppress restenosis, at least In part, in CAD patients with coronary inter- 
vention. 
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1103-3 Time Course of Transcardiac Interleukin-6 Release After 
Coronary Stenting for Stable Angina 
Joelle Kefer, Laurence M. Galanti, vE. University of Louvain, Brussels, 
Belgium. 
Background: Increases in circulating levels of interleukin-6 (IL-6) and C-reactive protein 
(CRP) have been reported after coronary balloon angioplasty, particularly in the context 
of unstable coronary syndromes. These changes could reflect inflammatory reactions 
within the coronary vasculature related to plaque unstability or to procedure-related vas- 
cular damage. 
Methods: To further investigate the influence of vascular trauma induced by stent implan- 
tation on the release of these inflammatory markers in patients with stable angina, we 
measured aortic and coronary sinus (CS) concentrations of IL-6 and CRP before, imme- 
diately and 2 hours after elective stent implantation in the proximal segment of the LAD in 
6 patients. 
Results: Before stenting, IL-6 concentrations were similar in CS and in aorta (3.049.32 
and 3.06?2.36 pg/ml; NS), the IL-6 CS/Aorta ratio averaging 0.99fo.12. Immediately and 
2 hours after stenting, the IL-6 CSlAorta ratio increased respectively to 1.1310.11 and to 
1.40x).61 (both pcO.04 vs before stenting) reflecting a significant transcardiac release: 
IL-6 concentrations increased in the CS to 3.15&?.42pg/ml (NS) immediately after and to 
7.99i4.71pgIml (p<O.Ol) 2 hours after stent implantation. CRP concentrations averaged 
3.10~.35mg/l in the aorta and 3.16t3.49 mgil in the CS before stenting and did not 
change during the study (respectively 4.3lk4.19 and 3.37+3.75 mg/l 2 hours after stent- 
Ing ; NS). 
Conclusions: Elective coronary stenting for stable angina results in a significant transcar- 
disc release of IL-6 detectable up to 2 hours after the procedure. 
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1. Med. Klinik rechts der Tsar, Munich, Germany 
Background: The functional 694Gn endothelial nitric oxide synthase (eNOS) polymor- 
phism has been found to be clinically relevant, with TT genotype as a risk factor. Since 
the relative contribution of genetic factors may decrease with age and may be more pro- 
nounced among younger men, we performed a specific analysis of male patients with 
coronary artery disease undergoing coronary stenting. 
Methods: We analyzed 1459 consecutive men; there were 639 patients < 60 years and 
620 patients 2 60 years. One-year mortality was the primacy endpoint of the study. The 
combined l-year incidence of death and myocardial infarction (Ml) was also assessed. 
Odds ratios (OR) and respective 95% confidence intelvats associated with carriage of 
the 694TT eNOS genotype are shown. 
Results: The 694TT eNOS genotype was associated with a significant risk increase for 
death at 1 year only among younger patients (figure). In patients < 60 years, the mortality 
was 5.7% in TT-carriers vs 0.9% in G-allele carriers (OR, 6.4 [2.t to 20.11, P=O.OOl). The 
difference was much less evident in patients t 60 years, with a mortality of 6% in n-car- 
riers and 3% In G-allele carriers (OR, 1.9 [0.77 to 5.101, P=O.2). The same was also true 
for the combined incidence of death and Ml at 1 year. When TT-carriers were compared 
to G-allele CSrriSrS. it was 6.6% vs 2.6% (P=O.O07) for younger men and 7.2% vs 4.3% in 
older men (P=O.3). 
Conclusions: The 694ll genotype can serve as a prognostic marker of an unfavorable 
outcome aner coronaiy stenting, especially among young men. 
1103-5 Accelerated Atherosclerotic Change in Saphenous Vein 
Bypass Graft Restenosis: Importance of the Lipid Core 
&eno S. Pess&& Andrew Farb, Deena K. Weber, Allen P. Burke, Renu Vinani. 
Armed Forces Institute of Pathology, Washington, Dw. of Columbia. 
Background: Advanced saphenous vein graft (SVG) plaques have ~30% larger lipid 
core content than plaques in native coronary arteries (CA’s). While stenting of SVG’s is 
superior to PTCA, SVG stent restenosis rates remain high. Despite the increased use of 
SVG stents, their morphologic features, the mechanism of atheroembolization, and the 
predictors of SVG stent restenosis are incompletely understood. 
Methods: Histology was performed on 16 stented SVG’s, implanted 290 days, from 13 
patients. A histologic success was defined as a stent area stenosis of 250% and resteno- 
sis as a stent stenosis of >50%. 
Results: Lipid core penetration (LCP) by the stent deep within the plaque was present in 
50% of cases, a nearly 2.fold increased frequency of LCP that is seen in native coronary 
artery stenting. Further, 75% of stents with lipid core penetration showed in-stent rest- 
enosis (vs. 25% without LCP, p<O.O5). LCP by the stent was associated with increased 
neointimal growth (Table). The neointima in restenotic segments showed smooth muscle 
cells admixed with fibrin and foamy macrophages. consistent with early atherosclerotic 
change and distinctive from restenosis lesions in native CA’s, 
Conclusions: Stenting of atherosclerotic SVG’s frequently results in lipid core panetra- 
tion by the stent, which accounts for acute atheroembolization and is associated with 
enhanced neointimal growth. Accelerated atherosclerosis is present in SVG in-stent rest- 
enosls, a morphology that differs from stent neointima in native CA’s, 
Stent neointima (NI) measurements 
NI Area (mm2) NI Thickness (mm) O/&tent Stenosis 
LCP Present 
LCP Absent 
P 
6.4i2.4 
2.4+1.0 
co.oOO1 
0.62+0.37 62i14 
0.25&plusmn;0.10 37221 
<O.OOl 0.02 
1103-6 Apolipoprotein E Genotype Predicts the Outcome After 
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Background: The T allele of the -219Gfl polymorphism and the ~4 allele of the gene 
encoding apolipoprotein E were found to be associated with susceptibility to coronary 
artery disease. We examined whether these alleles were also related to the risk of major 
adverse clinical events (MACE: death, myocardial infarction [Ml], target vessel revascu- 
larization [TVR]) aner coronary artery stenting. 
Methods: In 1650 consecutive patients with coronary artery disease, the occurrence of 
MACE was evaluated over 1 year after stent placement. Genotyping was based on the 
polymetase chain reaction and involved the TaqMan technique. 
Results: The frequencies of the -219T allele and the ~4 allele were 0.49 and 0.26, 
respectively. MI, TVR, and the combined incidence of MACE were significantly lower 
among carriers of the -219T allele compared to -219G allele carriers, with patients of 
genotype TT having the lowest risk (Table). In contrast, the risk of Ml, TVR or MACE was 
not found to be related to the ~4 allele (Table). 
-219GG -219GT -219TT P e4 none4 P 
Ml (%) 3.2 1.5 1.1 0.03 1.2 2.1 0.24 
TVR (%) 24.3 20.2 16.2 0.006 16.5 21 .o 0.24 
MACE (%) 26.1 23.2 18.2 0.01 20.3 23.6 0.14 
Conclusions: The apolipoprotein E genotype may serve as a prognostic marker of MI, 
TVR. and MACE after coronary artery stenting. The association is based on the presence 
of the -219T allele rather than the e4 allele. 
